The invention discloses an urazole chiral axis compound. The urazole chiral axis compound is represented by a formula I or II, wherein the R<1a> is selected from alkyl, halogen, phenyl, substituted phenyl and other groups shown in the descriptions, the R<5> is selected from halogen, alkyl and alkoxy, the R<6> and the R<7> are respectively and independently selected from an aliphatic substituent group and an aromatic substituent group, and the R<1b>, R<1c>, R<1d> and R<1e> are respectively and independently selected from hydrogen, halogen, phenyl, substituted phenyl, alkyl, alkoxy, hydroxyl, a ester group, an aldehyde group, a cyano group and amide. The R represents an aryl group free of a substituent group or provided with one or more of substituent groups, and the R' represents hydrogen or alkyl. The invention further discloses an asymmetric synthesis method of the compound. The high-yield high-ee-value urazole chiral axis compound is prepared through synthesis under the moderate reaction conditions. The synthesis method has very good substrate adaptability and can achieve synthesis of more than shown grams of the compound under the situation that the dosage of a catalyst is decreased. The compound can serve as a catalyst or a ligand for a certain asymmetric reactions.